Skip to main content
Asiri Ediriwickrema, MD, Hematology, Palo Alto, CA, Stanford Health Care

AsiriSaumyaEdiriwickremaMD

Hematology Palo Alto, CA

Hematologic Oncology

Instructor in Hematology

Dr. Ediriwickrema is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Ediriwickrema's full profile

Already have an account?

Education & Training

  • Stanford Health Care
    Stanford Health CareFellowship, Hematology and Medical Oncology, 2017 - 2020
  • Stanford Health Care-Sponsored Stanford University
    Stanford Health Care-Sponsored Stanford UniversityResidency, Internal Medicine, 2015 - 2017
  • Stanford Health Care-Sponsored Stanford University
    Stanford Health Care-Sponsored Stanford UniversityInternship, Internal Medicine, 2014 - 2015
  • Yale School of Medicine
    Yale School of MedicineClass of 2014
  • Massachusetts Institute of Technology
    Massachusetts Institute of TechnologyBS, Engineering , 2004 - 2008

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 2015 - 2025
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Hematology

Publications & Presentations

PubMed

Journal Articles

  • Acute bitemporal hemianopsia from a compressive anterior communicating artery aneurysm  
    Keung B, Ediriwickrema A, Bulsara K, Neurology and Clinical Neuroscience, 11/26/2014

Abstracts/Posters

  • Granulocyte Transfusions in a Cohort of Neutropenic Patients with Life-Threatening Infections and Hematologic Diseases
    Asiri Ediriwickrema, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019

Lectures

  • Comprehensive Cytokine Profiling of Patients with Advanced Systemic Mastocytosis Treated with Midostaurin 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018

Press Mentions

  • New Publication Demonstrates Power of Mission Bio’s Tapestri Platform to Track Minimal Residual Disease Related to Cancer Relapse
    New Publication Demonstrates Power of Mission Bio’s Tapestri Platform to Track Minimal Residual Disease Related to Cancer RelapseMarch 12th, 2020

Hospital Affiliations